Showing results (111-120 of 125) with videos related to
Sort By:
Pageof 13
Cancer|November 11, 2021
Evaluating the association of frailty with communication about aging-related concerns between older patients with advanced cancer and their oncologistsNikesha Gilmore, Huiwen Xu, Lee Kehoe, et al.Journal of Thrombosis and Haemostasis : JTH|March 27, 2024
Extending venous thromboembolism secondary prevention with apixaban in cancer patients. The EVE trialRobert D McBane, Charles L Loprinzi, Tyler Zemla, et al.JCO Oncology Practice|August 29, 2023
Sponsor Perspectives on the Impact of the COVID-19 Pandemic on Interventional Cancer Clinical Trial Protocols and Data QualityJoseph M Unger, Hillary Stires, Laura A Levit, et al.Plos One|May 3, 2014
Does KRAS testing in metastatic colorectal cancer impact overall survival? A comparative effectiveness study in a population-based sampleHeather Spencer Feigelson, Chan Zeng, Pamala A Pawloski, et al.JCO Global Oncology|February 14, 2022
Patient's Perspective on the Impact of COVID-19 on Cancer Treatment in NigeriaAdedayo Joseph, Bankole Olatosi, Mohammad Rifat Haider, et al.JCO Global Oncology|March 15, 2023
Examining Cancer Patients' Perceptions of the Impact of COVID-19 on Teleoncology: Findings From 15 Nigerian Outpatient Cancer ClinicsAdedayo Joseph, Abdul R Shour, Nwamaka N Lasebikan, et al.Clinical Medicine & Research|September 4, 2024
COVID-19-Related Treatment Cancellations and Oncology Patients' Psychological Health in NigeriaAdedayo Joseph, Abdul R Shour, Nwamaka N Lasebikan, et al.Journal of the National Comprehensive Cancer Network : JNCCN|March 13, 2026
Effects of Exercise on Cognitive Impairment in Patients Receiving Chemotherapy: A Multicenter Phase III Randomized Controlled TrialKaren M Mustian, Po-Ju Lin, Alisha Chakrabarti, et al.Cancer|December 10, 2021
A randomized study of genetic education versus usual care in tumor profiling for advanced cancer in the ECOG-ACRIN Cancer Research Group (EAQ152)Angela R Bradbury, Ju-Whei Lee, Jill Bennett Gaieski, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 6, 2021
E2112: Randomized Phase III Trial of Endocrine Therapy Plus Entinostat or Placebo in Hormone Receptor-Positive Advanced Breast Cancer. A Trial of the ECOG-ACRIN Cancer Research GroupRoisin M Connolly, Fengmin Zhao, Kathy D Miller, et al.Pageof 13